Ensign Peak Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $972K | Sell |
36,689
-136,201
| -79% | -$3.61M | ﹤0.01% | 1258 |
|
|
2025
Q1 | $4.18M | Sell |
172,890
-239,766
| -58% | -$5.79M | 0.01% | 673 |
|
|
2024
Q4 | $16.6M | Sell |
412,656
-39,355
| -9% | -$1.58M | 0.03% | 352 |
|
|
2024
Q3 | $28.6M | Hold |
452,011
| – | – | 0.05% | 264 |
|
|
2024
Q2 | $24M | Buy |
452,011
+165,851
| +58% | +$8.79M | 0.04% | 285 |
|
|
2024
Q1 | $23.5M | Sell |
286,160
-2,111
| -0.7% | -$173K | 0.04% | 298 |
|
|
2023
Q4 | $5.36M | Buy |
288,271
+1,650
| +0.6% | +$30.7K | 0.01% | 611 |
|
|
2023
Q3 | $3.17M | Buy |
286,621
+14,200
| +5% | +$157K | 0.01% | 693 |
|
|
2023
Q2 | $4.42M | Buy |
272,421
+28,100
| +12% | +$456K | 0.01% | 620 |
|
|
2023
Q1 | $4.07M | Buy |
+244,321
| New | +$4.07M | 0.01% | 625 |
|